Dr. John Cush RheumNow
1 year 8 months ago
RA-ILD in the Spotlight at #ACR24
Over the past 5 years, there has been growing interest in RA-ILD due to its relative prevalence and severity. This seems to be one of the few RA outcomes not improving much, even with the advent of expanded treatment options.… https://t.co/MIPXW9EgVa https://t.co/kX0hDq8NTH
Dr. John Cush RheumNow
1 year 8 months ago
The Case for JAKi in PMR
Dr. David Liew abstract 0858, Baricitinib in Early Polymyalgia Rheumatica (BACHELOR Study), presented at #ACR24.
https://t.co/NLF75PuMOb https://t.co/FpUUdbtrwf
Dr. John Cush RheumNow
1 year 8 months ago
What Lies Beneath: Understanding Nailfold Capillaroscopy
Capillaroscopy is a non-invasive imaging technique used for the in vivo assessment of the microcirculation. It can be performed using various optical instruments, but only the dermatoscope and videocapillaroscope have… https://t.co/JK9EvuxWEV https://t.co/77AcwfKIzE
Dr. John Cush RheumNow
1 year 8 months ago
Cyclophosphomide vs Mycophenolate vs Tacrolimus in Lupus Nephritis
Dr. Mike Putman discusses abstract 0670, presented at #ACR24.
https://t.co/QiWdioliDi https://t.co/DPRA58vyUn
Dr. John Cush RheumNow
1 year 8 months ago
ANA+ and no Autoimmune Disease? Check the liver
Dr. Janet Pope discusses abstract 0627, presented at #ACR24.
https://t.co/4HV2kqjibL https://t.co/kmVcvUZtRQ
Dr. John Cush RheumNow
1 year 8 months ago
Dreaming of Relief: The Importance of Sleep in Lupus and Rheumatoid Arthritis
Sleep is crucial for managing inflammation and health. In rheumatic diseases like lupus and RA, disrupted sleep is common and can worsen symptoms and disease progression. Experts stress the importance… https://t.co/u3DmSdaoVN https://t.co/ncMX3uhOMw
Dr. John Cush RheumNow
1 year 8 months ago
#ACR Best 2024 - Day 4
Although the last day of #ACR24 was but a half day - it was chock full of gems, many coming from the late breaking abstracts presented today. As chosen by the RheumNow faculty, here are some highlight presentations you need to know about.… https://t.co/GseDW1ZfkL https://t.co/35aJs0yG8i
Dr. John Cush RheumNow
1 year 8 months ago
The Psoriatic March: PsA before PsO
https://t.co/lRCrzdKX7Z https://t.co/eabYe3GXrM
Dr. John Cush RheumNow
1 year 8 months ago
Worried about CV Risk and JAKi? What about the Steroids?
Dr. David Liew discusses abstracts 1981 and 2673, presented at #ACR24
https://t.co/OkMgIqxl2A https://t.co/1DVapGcWUn
Many of our diseases are made worse by obesity, notably rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Much of the refractory pain and suffering from these conditions might be attributable to obesity, so active questions will be raised about how GLP-1 agonists can influence the diseases we treat.
When should you consider off-label use of JAKi?
